Department of Biotechnology, University of Natural Resources and Applied Life Sciences Vienna, Muthgasse 18, 1190 Vienna, Austria.
J Chromatogr A. 2010 Oct 1;1217(40):6203-13. doi: 10.1016/j.chroma.2010.07.074. Epub 2010 Aug 11.
To design a generic purification platform and to combine the advantages of fusion protein technology and matrix-assisted refolding, a peptide affinity medium was developed that binds inclusion body-derived N(pro) fusion proteins under chaotropic conditions. Proteins were expressed in Escherichia coli using an expression system comprising the autoprotease N(pro) from Pestivirus, or its engineered mutant called EDDIE, with C-terminally linked target proteins. Upon refolding, the autoprotease became active and cleaved off its fusion partner, forming an authentic N-terminus. Peptide ligands binding to the autoprotease at 4 M urea were screened from a combinatorial peptide library. A group of positive peptides were identified and further refined by mutational analysis. The best binders represent a common motif comprising positively charged and aromatic amino acids, which can be distributed in a random disposition. Mutational analysis showed that exchange of a single amino acid within the peptide ligand caused a total loss of binding activity. Functional affinity media comprising hexa- or octapeptides were synthesized using a 15-atom spacer with terminal sulfhydryl function and site-directed immobilization of peptides derivatized with iodoacetic anhydride. The peptide size was further reduced to dipeptides comprising only one positively charged and one aromatic amino acid. Based on this, affinity media were prepared by immobilization of a poly amino acid comprising lysine or arginine, and tryptophan, phenylalanine, or tyrosine, respectively, in certain ratios. Binding capacities were in the range of 7-15 mg protein mL(-1) of medium, as could be shown for several EDDIE fusion proteins. An efficient protocol for autoproteolytic cleavage using an on-column refolding method was implemented.
为设计一个通用的纯化平台,并结合融合蛋白技术和基质辅助复性的优点,开发了一种肽亲和介质,该介质在变性条件下结合包含体衍生的 N(pro)融合蛋白。使用包含来自 Pestivirus 的自蛋白酶 N(pro)或其称为 EDDIE 的工程突变体的表达系统,在大肠杆菌中表达带有 C 末端连接的靶蛋白的融合蛋白。复性后,自蛋白酶变得活跃并将其融合伴侣切割下来,形成真实的 N 末端。从组合肽文库中筛选与 4 M 脲中的自蛋白酶结合的肽配体。鉴定了一组阳性肽,并通过突变分析进一步进行了优化。最佳结合物代表了一种包含正电荷和芳香族氨基酸的共同基序,可随机分布。突变分析表明,肽配体中单个氨基酸的交换会导致结合活性完全丧失。使用具有末端巯基功能的 15 个原子间隔物和用碘乙酰胺衍生的肽的定点固定合成包含六肽或八肽的功能亲和介质。肽的大小进一步减小到仅包含一个正电荷和一个芳香族氨基酸的二肽。在此基础上,通过固定包含赖氨酸或精氨酸和色氨酸、苯丙氨酸或酪氨酸的多氨基酸,分别以一定的比例制备亲和介质。结合容量在 7-15mg 蛋白质 mL(-1)的介质范围内,可用于几种 EDDIE 融合蛋白。实施了一种使用柱上复性方法进行自蛋白酶切割的有效方案。